Scott S. Deprescribing: a call for research that supports implementation in practice. In. Vol 29: Oxford University Press UK; 2021:525–526.

Okeowo D, Patterson A, Boyd C, Reeve E, Gnjidic D, Todd A. Clinical practice guidelines for older people with multimorbidity and life-limiting illness: what are the implications for deprescribing? Therapeutic Adv drug Saf. 2018;9(11):619–30.

Article  Google Scholar 

Shrestha S, Poudel A, Forough AS, Steadman KJ, Nissen LM. A systematic review on methods for developing and validating deprescribing tools for older adults with limited life expectancy. Int J Pharm Pract. 2023;31(1):3–14.

Article  PubMed  Google Scholar 

Reeve E, Gnjidic D, Long J, Hilmer S. A systematic review of the emerging definition of ‘deprescribing’with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80(6):1254–68.

Article  PubMed  PubMed Central  Google Scholar 

Organization WH. Medication safety in polypharmacy: technical report World Health Organization;2019.

McNeil MJ, Kamal AH, Kutner JS, Ritchie CS, Abernethy AP. The burden of polypharmacy in patients near the end of life. J Pain Symptom Manag. 2016;51(2):178–83. e172.

Article  Google Scholar 

McNeill R, Hanger HC, Chieng J, Chin P. Polypharmacy in palliative care: two deprescribing tools compared with a clinical review. J Palliat Med. 2021;24(5):661–7.

Article  PubMed  Google Scholar 

Navid P, Nguyen L, Jaber D, et al. Attitudes toward deprescribing among adults with heart failure with preserved ejection fraction. J Am Geriatr Soc. 2021;69(7):1948–55.

Article  PubMed  PubMed Central  Google Scholar 

Shega JW, Ellner L, Lau DT, Maxwell TL. Cholinesterase inhibitor and N-methyl-D-aspartic acid receptor antagonist use in older adults with end-stage dementia: a survey of hospice medical directors. J Palliat Med. 2009;12(9):779–83.

Article  PubMed  PubMed Central  Google Scholar 

Barrett MJ, Sargent L, Nawaz H, Weintraub D, Price ET, Willis AW. Antimuscarinic anticholinergic medications in Parkinson disease: to prescribe or deprescribe? Mov Disorders Clin Pract. 2021;8(8):1181–8.

Article  Google Scholar 

Iyer S, Naganathan V, McLachlan AJ, Le Conteur DG. Medication withdrawal trials in people aged 65 years and older: a systematic review. Drugs Aging. 2008;25:1021–31.

Article  PubMed  Google Scholar 

Anderson K, Stowasser D, Freeman C, Scott I. Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ open. 2014;4(12):e006544.

Article  PubMed  PubMed Central  Google Scholar 

Moonen JE, Foster-Dingley JC, de Ruijter W, et al. Effect of discontinuation of antihypertensive treatment in elderly people on cognitive functioning—the DANTE Study Leiden: a randomized clinical trial. JAMA Intern Med. 2015;175(10):1622–30.

Article  PubMed  Google Scholar 

Todd A, Nazar H, Pearson S, Andrew I, Baker L, Husband A. Inappropriate prescribing in patients accessing specialist palliative day care services. Int J Clin Pharm. 2014;36:535–43.

Article  CAS  PubMed  Google Scholar 

Oliveira L, Ferreira MO, Rola A, Magalhães M, Ferraz Gonçalves J. Deprescription in advanced cancer patients referred to palliative care. J Pain Palliat Care Pharm. 2016;30(3):201–5.

Google Scholar 

LeBlanc TW, McNeil MJ, Kamal AH, Currow DC, Abernethy AP. Polypharmacy in patients with advanced cancer and the role of medication discontinuation. Lancet Oncol. 2015;16(7):e333–41.

Article  PubMed  Google Scholar 

Paque K, Vander Stichele R, Elseviers M, et al. Barriers and enablers to deprescribing in people with a life-limiting disease: a systematic review. Palliat Med. 2019;33(1):37–48.

Article  PubMed  Google Scholar 

Kierner KA, Weixler D, Masel EK, Gartner V, Watzke HH. Polypharmacy in the terminal stage of cancer. Support Care Cancer. 2016;24:2067–74.

Article  PubMed  Google Scholar 

Garfinkel D, Zur-Gil S, Ben-Israel H. The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. IMAJ-RAMAT GAN-. 2007;9(6):430.

Google Scholar 

Talebreza S, McPherson ML. Recognizing and managing polypharmacy in advanced illness. Med Clin. 2020;104(3):405–13.

Google Scholar 

Hoel RW, Connolly RMG, Takahashi PY. Polypharmacy management in older patients. Paper presented at: Mayo Clinic Proceedings2021.

Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–57.

Article  PubMed  Google Scholar 

Todd A, Al-Khafaji J, Akhter N, et al. Missed opportunities: unnecessary medicine use in patients with lung cancer at the end of life–an international cohort study. Br J Clin Pharmacol. 2018;84(12):2802–10.

Article  PubMed  PubMed Central  Google Scholar 

Todd A, Husband A, Andrew I, Pearson S-A, Lindsey L, Holmes H. Inappropriate prescribing of preventative medication in patients with life-limiting illness: a systematic review. BMJ Supportive Palliat care. 2017;7(2):113–21.

Article  Google Scholar 

Braun V. Thematic analysis: a practical guide. London: SAGE; 2022.

Book  Google Scholar 

Braun V, Clarke V. Reflecting on reflexive thematic analysis. Qualitative Res Sport Exerc Health. 2019;11(4):589–97.

Article  Google Scholar 

Braun V, Clarke V. To saturate or not to saturate? Questioning data saturation as a useful concept for thematic analysis and sample-size rationales. Qualitative Res Sport Exerc Health. 2021;13(2):201–16.

Article  Google Scholar 

Malterud K, Siersma VD, Guassora AD. Sample size in qualitative interview studies: guided by Information Power. Qual Health Res. 2015;26(13):1753–60.

Article  Google Scholar 

Green AR, Boyd CM, Gleason KS, et al. Designing a primary care–based deprescribing intervention for patients with dementia and multiple chronic conditions: a qualitative study. J Gen Intern Med. 2020;35:3556–63.

Article  PubMed  PubMed Central  Google Scholar 

Crutzen S, Baas G, Abou J, et al. Barriers and enablers of older patients to deprescribing of cardiometabolic medication: a focus group study. Front Pharmacol. 2020;11:1268.

Article  PubMed  PubMed Central  Google Scholar 

Todd A, Jansen J, Colvin J, McLachlan AJ. The deprescribing rainbow: a conceptual framework highlighting the importance of patient context when stopping medication in older people. BMC Geriatr. 2018;18(1):1–8.

Article  Google Scholar 

Graabæk T, Lundby C, Ryg J, Søndergaard J, Pottegård A, Nielsen DS. I simply don’t know, because I don’t know which drugs I get: perspectives on deprescribing among older adults with limited life expectancy and their relatives. Basic Clin Pharmacol Toxicol. 2021;128(1):115–27.

Article  PubMed  Google Scholar 

Weir K, Nickel B, Naganathan V, et al. Decision-making preferences and deprescribing: perspectives of older adults and companions about their medicines. Journals Gerontology: Ser B. 2018;73(7):e98–107.

Article  Google Scholar 

Seewoodharry M, Khunti K, Davies MJ, Gillies C, Seidu S. Attitudes of older adults and their carers towards de-prescribing: a systematic review. Diabet Med. 2022;39(7):e14801.

Article  PubMed  Google Scholar 

Plakiotis C, Bell JS, Jeon Y-H, Pond D, O’Connor DW. Deprescribing psychotropic medications in aged care facilities: the potential role of family members. GeNeDis 2014: Geriatr 2015:29–43.

Scott IA, Anderson K, Freeman CR, Stowasser DA. First do no harm: a real need to deprescribe in older patients. Med J Aust. 2014;201(7):390–2.

Article  PubMed  Google Scholar 

Foley R-A, Hurard LL, Cateau D, Koutaissoff D, Bugnon O, Niquille A. Physicians’, nurses’ and pharmacists’ perceptions of determinants to deprescribing in nursing homes considering three levels of action: a qualitative study. Pharmacy. 2020;8(1):17.

Article  PubMed  PubMed Central  Google Scholar 

Scott S, Twigg MJ, Clark A, et al. Development of a hospital deprescribing implementation framework: a focus group study with geriatricians and pharmacists. Age Ageing. 2020;49(1):102–10.

Article  Google Scholar 

Wallis KA, Andrews A, Henderson M. Swimming against the tide: primary care physicians’ views on deprescribing in everyday practice. Annals Family Med. 2017;15(4):341–6.

Article  Google Scholar 

D’Avanzo B, Agosti P, Reeve E, et al. Views of medical practitioners about deprescribing in older adults: findings from an Italian qualitative study. Maturitas. 2020;134:29–33.

Article  PubMed  Google Scholar 

Farrell B, Raman-Wilms L, Sadowski CA et al. A proposed Curricular Framework for an Interprofessional Approach to Deprescribing. Med Sci Educ 2023:1–17.